首页 | 本学科首页   官方微博 | 高级检索  
检索        

奈达铂联合替加氟治疗晚期食管癌的临床观察
作者单位:Lianggeng Xiong(Department of Medical Ontology, The Second People Hospital of Dazhou, Dazhou 635000, China);Youshan Li(Thoracic Surgical Department, The Second People Hospital of Dazhou, Dazhou 635000, China)  
摘    要:

关 键 词:化疗治疗  晚期食管癌  5-Fu方案  胃肠功能紊乱  中晚期食管  对照组  氟脲嘧啶  骨髓抑制
收稿时间:28 November 2010

Short-term effects of nedaplatin plus futraful chemotherapy in treatment of advanced esophageal carcinoma
Authors:Lianggeng Xiong  Youshan Li
Institution:[1]Department of Medical Oncology, The Second People Hospital of Dazhou, Dazhou 635000, China [2]Thoracic Surgical Department, The Second People Hospital of Dazhou, Dazhou 635000, China
Abstract:Objective:To observe the efficacy and the side effects of nedaplatin with futraful in the treatment of advanced esophageal carcinoma. Methods:Observing group NDP/FT-207 regimen:given nedaplatin 80-100 mg/m2 on day 1 and futraful 500-600 mg/m2 on day 1 to 5;control group:DDP/5-Fu regimen received cisplatin 80-100 mg/m2 on day 1 and 5-Fluorouracil 500-750 mg/m2 on day 1 to 5. In both groups per 28 days was a cycle, 2-3 cycles were one course. Results:Response and toxicity could be assessed in all the 78 patients, 42 patients were in observing group, the other 36 patients were in control group. The response rate of patients treated by NDP/FT-207 and DDP/5-Fu were 57.1% (24/42) and 50% (18/36) respectively. The two groups have no significant difference. The toxicities as gastrointestinal disorders and myelosuppression in observing group was lighter than those in control group. Conclusion:The combination of NDP and FT-207 is a safer and effective regimen.
Keywords:esophageal carcinoma  nedaplatin  futraful
本文献已被 维普 万方数据 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号